Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
00 a.m. EST
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
BD Board Increases Dividend
Mon, November 21, 2011
Sun, November 20, 2011
Fri, November 18, 2011
Thu, November 17, 2011
Wed, November 16, 2011
Tue, November 15, 2011
Mon, November 14, 2011
[ Mon, Nov 14th 2011 ] - Market Wire
30 AM Eastern Time
Sun, November 13, 2011
Sat, November 12, 2011
Fri, November 11, 2011

POZEN to Present at the Piper Jaffray 23rd Annual Healthcare Conference


//health-fitness.news-articles.net/content/2011/ .. r-jaffray-23rd-annual-healthcare-conference.html
Published in Health and Fitness on Thursday, November 17th 2011 at 4:39 GMT by Market Wire   Print publication without navigation


CHAPEL HILL, N.C.--([ ])--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that John R. Plachetka, Pharm.D., the Companyas Chairman, President and Chief Executive Officer, will present at the Piper Jaffray 23rd Annual Healthcare Conference on Wednesday, November 30, 2011 at 2:30 p.m. (ET), at The New York Palace Hotel. Dr. Plachetkaas presentation will be webcast and available for replay on POZENas home page at [ www.pozen.com ].

About POZEN

POZEN Inc. is a progressive pharmaceutical company that is transforming how the healthcare industry addresses unmet medical needs. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products in two years a" something almost no other small pharmaceutical company has done. Funded by these two milestone/royalty streams, POZEN is now creating a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.

The Companyas common stock is traded on The NASDAQ Global Market under the symbol aPOZNa. For more detailed company information, including copies of this and other press releases, please visit [ www.pozen.com ].


Publication Contributing Sources